Influenza vaccine immunogenicity in 6- to 23-month-old children: Are identical antigens necessary for priming?

Pediatrics

Volumn 118, Issue 3, 2006, Pages

  Walter, Emmanuel B ^a,f   Neuzil, Kathleen M ^b   Zhu, Yuwei ^c   Fairchok, Mary P ^d,e   Gagliano, Martha E ^f   Monto, Arnold S ^g   Englund, Janet A ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e MADIGAN ARMY MEDICAL CENTER   (United States)

^f DUKE UNIVERSITY   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Children; Immunogenicity; Inactivated influenza vaccine

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; H1N1 ANTIGEN; H1N2 ANTIGEN; H3N2 ANTIGEN; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; TRIPLE VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; OPEN STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; VACCINATION; ANTIBODY PRODUCTION; FEMALE; IMMUNIZATION; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; SEASON;

ANTIBODY FORMATION; ANTIGENS, VIRAL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROSPECTIVE STUDIES; SEASONS;

EID: 33751426980     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0198     Document Type: Article

References (24)

1. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis. 1987;136:550-555
2. Neuzil KM, Mellen BG, Wright PF. Effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225-231
3. Neuzil KM, Wright PF, Mitchel EF Griffin MR. Burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr. 2000;137:856-864
4. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239
5. Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med. 2002;347:2097-2103
6. Colombo C, Argiolas L, La Vecchia C, Negri E, Meloni G, Meloni T. Influenza vaccine in healthy preschool children. Rev Epidemiol Sante Publique. 2001;49:157-162
7. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990; the pediatric experience. Pediatr Infect Dis J. 2001;20:733-740
8. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child. 1991;145:445-448
9. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6-36-month-old children in day care. Arch Pediatr Adol Med. 1995;149:1113-1117
10. Hoberman A, Greenberg DP, Paradise JI, et al. Efficacy of inactivated influenza vaccine in preventing acute otitis media in young children. JAMA. 2003;290:1608-1616
11. Ruben FL. Inactivated influenza virus vaccines in children. Clin Infect Dis. 2004;38:678-688
12. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep. 2004;53:743]. MMWR Recomm Rep. 2004;53(RR-6):1-40
13. Englund JA, Walter EB, Fairchok MP Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6-23-month-old children. Pediatrics. 2005;115:1039-1047
14. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 versus 2 doses. Pediatrics. 2005;116:153-159
15. Walter E, Sung J, Kahn Meine E, Drucker RP, Clements DA. Lack of effectiveness of a letter reminder for annual influenza immunization of asthmatic children. Pediatr Infect Dis J. 1997;16:1187-1188
16. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972;70:767-777
17. Dowdle WR, Coleman MT, Mostow SR, Kaye HS, Schoenbaum SC. Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J. 1973;49:159-163
18. Centers for Disease Control and Prevention. Update: influenza activity - United States, 2004-2005 season. MMWR Morb Mortal Wkly Rep. 2005:54:328-331
19. Centers for Disease Control and Prevention. Protection against viral hepatitis recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep. 1990:39(RR-2):1-26
20. Middleman AB, Kozinetz CA, Robertson LM, DuRant RH, Emans SJ. The effect of late doses on the achievement of seroprotection and antibody titer levels with hepatitis B immunization among adolescents. Pediatrics. 2001;107:1065-1069
21. Halsey NA, Moulton LH, O'Donovan JC, et al. Hepatitis B vaccine administered to children and adolescents at yearly intervals. Pediatrics. 1999;103:1243-1247
22. Harmon MW, Rota PA, Walls HH, Kendal AP. Antibody responses in humans to influenza type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol. 1988;26:333-337
23. Stephenson Iain, Nicholson KG, Gluck R, et al. Safety and antigenicity of whole virus and subunit influenza/HongKnog/1073/99 (H9N2) vaccine in healthy adults: phase I randomized trial. Lancet. 2003;362:1959-1966
24. Centers for Disease Control and Prevention. Estimated influenza vaccine coverage among adults and children: United States, September 2004-January 2005. MMWR Morb Mortal Wkly Rep. 2005;54:304-307